Bromhexine delayed-release pharmaceutical form
    1.
    发明授权
    Bromhexine delayed-release pharmaceutical form 失效
    溴马酸缓释药物形式

    公开(公告)号:US4438091A

    公开(公告)日:1984-03-20

    申请号:US393760

    申请日:1982-06-30

    摘要: This invention relates to vehicles for the administration of bromhexine. More specifically, this invention relates to a composition for the delayed release of bromhexine which comprises (i) spheroid particles or tablets comprised of (a) bromhexine and/or acid addition salts thereof and (b) at least one pharmacologically acceptable acid or acidic substance, the total amount of acid substance from acid addition salts present and the acid or acidic substance being in a ratio of at least 2 mols to 1 mol of bromhexine, and (ii) a coating surrounding said spheroid particles or tablets, said coating being comprised of from about 50 to 100 percent by weight of acid-insoluble lacquers soluble in intestinal juices and from about 0 to 50 percent by weight of lacquers insoluble in gastric and intestinal juices and said coating being present in an amount of from about 2 to 30 percent by weight, based upon the weight of the spheroid particles or tablets.

    摘要翻译: 本发明涉及用于施用溴己定的载体。 更具体地说,本发明涉及一种用于延迟释放溴己烯的组合物,其包括(i)由(a)溴己酮和/或其酸加成盐组成的球状颗粒或片剂,和(b)至少一种药理学上可接受的酸或酸性物质 ,存在酸加成盐的酸性物质的总量和酸或酸性物质的比例为至少2摩尔至1摩尔溴己定的比例,和(ii)围绕所述球状颗粒或片剂的涂层,所述涂层包括 约50至100重量%的可溶于肠液的酸不溶性漆和约0至50重量%不溶于胃肠和肠液的漆,并且所述涂层以约2至30重量%的量存在 ,基于球状颗粒或片剂的重量。

    Oral mopidamol preparation
    2.
    发明授权
    Oral mopidamol preparation 失效
    口服莫匹达莫制剂

    公开(公告)号:US4596705A

    公开(公告)日:1986-06-24

    申请号:US539998

    申请日:1983-10-07

    摘要: This invention relates to vehicles for the administration of mopidamol. More specifically, this invention relates to a method of treating cardiovascular disorders, malignancy, or thrombosis in a host in need of such treatment which comprises administering to said host a cardiovascularly, antimetastic, or antithrombotic effective amount of a composition comprised of (i) mopidamol or an acid addition salt thereof and (ii) at least one pharmacologically acceptable acid or acid substance, the total amount of acid from acid addition salt present and acid or acid substance being in a ratio of at least about 1 acid equivalent to 1 mol of mopidamol.

    摘要翻译: 本发明涉及给予莫匹达莫的载体。 更具体地说,本发明涉及在需要这种治疗的宿主中治疗心血管疾病,恶性肿瘤或血栓形成的方法,该方法包括向所述宿主施用心血管,抗重复或抗血栓形成的有效量的组合物,所述组合物包含(i)莫比达莫 或其酸加成盐和(ii)至少一种药理学上可接受的酸或酸物质,存在酸加成盐的酸的总量和酸或酸性物质的比例为至少约1当量酸1摩尔 莫比达莫

    Oral mopidamol preparation
    3.
    发明授权
    Oral mopidamol preparation 失效
    口服莫匹达莫制剂

    公开(公告)号:US4650664A

    公开(公告)日:1987-03-17

    申请号:US772166

    申请日:1985-09-03

    摘要: This invention relates to vehicles for the administration of mopidamol. More specifically, this invention relates to a method of treating cardiovascular disorders, malignancy, or thrombosis in a host in need of such treatment which comprises administering to said host a cardiovascularly, antimetastic, or antithrombotic effective amount of a composition comprised of (i) mopidamol or an acid addition salt thereof and (ii) at least one pharmacologically acceptable acid or acid substance, the total amount of acid from acid addition salt present and acid or acid substance being in a ratio of at least about 1 acid equivalent to 1 mol of mopidamol or its acid addition salt.

    摘要翻译: 本发明涉及给予莫匹达莫的载体。 更具体地说,本发明涉及在需要这种治疗的宿主中治疗心血管疾病,恶性肿瘤或血栓形成的方法,该方法包括向所述宿主施用心血管,抗重复或抗血栓形成的有效量的组合物,所述组合物包含(i)莫比达莫 或其酸加成盐和(ii)至少一种药理学上可接受的酸或酸物质,存在酸加成盐的酸的总量和酸或酸性物质的比例为至少约1当量酸1摩尔 莫比达莫或其酸加成盐。

    Injection molded microoptics
    7.
    发明申请
    Injection molded microoptics 有权
    注塑微光学

    公开(公告)号:US20070029277A1

    公开(公告)日:2007-02-08

    申请号:US11195147

    申请日:2005-08-02

    IPC分类号: B29D11/00 B29C35/08 B29C45/00

    摘要: A wafer-scale apparatus and method is described for the automation of forming, aligning and attaching two-dimensional arrays of microoptic elements on semiconductor and other image display devices, backplanes, optoelectronic boards, and integrated optical systems. In an ordered fabrication sequence, a mold plate comprised of optically designed cavities is formed by reactive ion etching or alternative processes, optionally coated with a release material layer and filled with optically specified materials by an automated fluid-injection and defect-inspection subsystem. Optical alignment fiducials guide the disclosed transfer and attachment processes to achieve specified tolerances between the microoptic elements and corresponding optoelectronic devices and circuits. The present invention applies to spectral filters, waveguides, fiber-optic mode-transformers, diffraction gratings, refractive lenses, diffractive lens/Fresnel zone plates, reflectors, and to combinations of elements and devices, including microelectromechanical systems (MEMS) and liquid crystal device (LCD) matrices for adaptive, tunable elements. Preparation of interfacial layer properties and attachment process embodiments are taught.

    摘要翻译: 描述了用于在半导体和其他图像显示装置,背板,光电板和集成光学系统上形成,对准和附着微量元件的二维阵列的自动化的晶片级装置和方法。 在有序的制造顺序中,由光学设计的空腔构成的模具板通过反应离子蚀刻或可选的工艺形成,任选地涂覆有释放材料层,并通过自动化流体注入和缺陷检查子系统填充光学特定的材料。 光学校准基准指导所公开的转移和附着过程以实现微光学元件与对应的光电器件和电路之间的特定公差。 本发明适用于光谱滤波器,波导管,光纤模式变压器,衍射光栅,折射透镜,衍射透镜/菲涅耳带片,反射器以及元件和器件的组合,包括微机电系统(MEMS)和液晶器件 (LCD)矩阵,用于自适应,可调元素。 教导界面层性质和附着工艺实施例的制备。

    Fire alarm
    9.
    发明授权
    Fire alarm 失效
    火警

    公开(公告)号:US5568133A

    公开(公告)日:1996-10-22

    申请号:US570814

    申请日:1995-12-12

    IPC分类号: G08B17/113 G08B23/00

    CPC分类号: G08B17/113

    摘要: Upon insertion of a fire alarm insert into a corresponding fire alarm mounting, the insert covers the mounting. The insert has a movable fastening comprising a ring, for example, for fastening the insert to the mounting. Indicator elements are included for indicating proper positioning of the insert relative to the mounting.

    摘要翻译: 在将火警报警插入物插入相应的火灾报警装置后,插入物将覆盖安装件。 插入件具有可移动的紧固件,其包括例如用于将插入件紧固到安装件上的环。 包括指示元件用于指示插入件相对于安装件的正确定位。